United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
These 3 Stocks Lowered Their Share Counts Drastically in Q1
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?
SDZNY or UTHR: Which Is the Better Value Stock Right Now?
United Therapeutics Corporation (UTHR) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Jim Simons' fund bet early on Micron; Here's the fund's top stocks now
United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference
United Therapeutics Corporation (UTHR) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
CPRX or UTHR: Which Is the Better Value Stock Right Now?
Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference
United Therapeutics Corporation Presents New Data from TETON-1, ADVANCE OUTCOMES, and Additional Research in Pulmonary Hypertension and Pulmonary Fibrosis at ATS 2026
UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcoa, Chiron Real Estate, Clear Secure, Fortinet, Fresh Pet, Kennametal, Oracle, PayPal, United Therapeutics, and More
United Therapeutics Corporation (UTHR) Q1 2026 Earnings Call Transcript
United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
United Therapeutics Corporation Reports First Quarter 2026 Financial Results
Ahead of United Therapeutics (UTHR) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors
United Therapeutics Corporation $UTHR Shares Bought by Comerica Bank
United Therapeutics (NASDAQ:UTHR) CFO Sells $209,609.40 in Stock
United Therapeutics (UTHR) to Report Q1 Results: Wall Street Expects Earnings Growth
United Therapeutics: The Future Lies With Manufactured Organs
United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026
Asset Management One Co. Ltd. Has $11.70 Million Stake in United Therapeutics Corporation $UTHR
CPRX or UTHR: Which Is the Better Value Stock Right Now?
United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
Christopher Patusky Sells 1,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics (NASDAQ:UTHR) EVP Sells $4,787,606.00 in Stock
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,513,420.00 in Stock
James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics Target of Unusually High Options Trading (NASDAQ:UTHR)
James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares
James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
Here Are Friday’s Top Wall Street Analyst Research Calls: Autodesk, Delek US Holdings, Insmed, Nike, Nutanix, ServiceNow, Shake Shack, Southern Copper, Veeva Systems, and More
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure
886 Shares in United Therapeutics Corporation $UTHR Acquired by BAM Wealth Management LLC
Element Squared LLC Acquires New Position in United Therapeutics Corporation $UTHR